Manulife (Manufacturers Life Insurance)’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.5M Sell
58,859
-2,036
-3% -$456K 0.01% 729
2025
Q4
$12.7M Sell
60,895
-5,320
-8% -$1.1M 0.01% 778
2025
Q3
$13.2M Buy
66,215
+7,964
+14% +$1.49M 0.01% 750
2025
Q2
$10.1M Sell
58,251
-20,881
-26% -$3.4M 0.01% 842
2025
Q1
$12.3M Sell
79,132
-3,823
-5% -$546K 0.01% 753
2024
Q4
$11.4M Buy
82,955
+11,648
+16% +$1.53M 0.01% 818
2024
Q3
$10.6M Buy
71,307
+23,595
+49% +$3.19M 0.01% 871
2024
Q2
$6.51M Sell
47,712
-6,814
-12% -$927K 0.01% 1048
2024
Q1
$8.24M Buy
54,526
+31,738
+139% +$4.53M 0.01% 951
2023
Q4
$2.87M Sell
22,788
-2,785
-11% -$278K ﹤0.01% 1357
2023
Q3
$2.39M Sell
25,573
-19,716
-44% -$1.84M ﹤0.01% 1381
2023
Q2
$4.04M Sell
45,289
-5,739
-11% -$499K ﹤0.01% 1189
2023
Q1
$5.47M Hold
51,028
﹤0.01% 1030
2022
Q4
$6.17M Buy
51,028
+387
+0.8% +$44.9K ﹤0.01% 978
2022
Q3
$5.2M Buy
50,641
+6,606
+15% +$626K ﹤0.01% 1026
2022
Q2
$4.15M Buy
44,035
+2,569
+6% +$242K ﹤0.01% 1173
2022
Q1
$4.81M Buy
+41,466
New +$4.8M ﹤0.01% 1208

Other funds holding ASND

Manulife (Manufacturers Life Insurance)'s ASND Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Ascendis Pharma A/S (ASND) stake by 3.3% in Q1 2026, selling an estimated $456K and leaving 58,859 shares worth $13.5M. The position accounts for 0.01% of the portfolio, ranked #729.

Manulife (Manufacturers Life Insurance) first reported a position in ASND in Q1 2022 and has held it in 17 quarters since. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 58,859 shares of Ascendis Pharma A/S worth $13.5M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,036 Ascendis Pharma A/S shares in Q1 2026, an estimated $456K.
  • Ascendis Pharma A/S made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #729 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Ascendis Pharma A/S in Q1 2022 and has held it in 17 quarters since.
  • 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.